Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Jan;63(1):68–72.

T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus.

O Pontesilli, H P Chase, P Carotenuto, M J Herberger, A R Hayward
PMCID: PMC1577341  PMID: 2937583

Abstract

Initial reports of blood T cell subsets in insulin-dependent (type I) diabetes mellitus (IDDM) are conflicting and, consequently, difficult to relate to animal models of the disease. To minimize technical artefacts, which may have contributed to previous results, we used direct immunofluorescence on whole blood and counted 3,000 lymphocytes by flow cytometer. Forty-two IDDM patients divided in three groups of 14 according to the disease duration and 12 age and sex matched controls were studied for T3, T4, T8 and HLA-DR expression. No statistically significant differences were found in their total blood lymphocyte counts or in the percentage of T3, T4 and T8 positive cells, although mild lymphopenia was found in the group of long-standing diabetics. The percentage of activated T cells, identified as T3+/DR+ cells, was significantly increased in the groups of patients studied more than a month after diagnosis and in four of 14 patients studied within a month from diagnosis. Seven new onset IDDM patients were studied for co-expression of T8 and Leu 15 antigens (putative suppressor cell phenotype), but no significant differences was found compared with controls. We conclude that T4/T8 ratio abnormalities previously reported in Ficoll separated cells are not reproduced when unseparated cells are analysed by flow cytometry, although the presence of HLA-DR+ T cells is confirmed.

Full text

PDF
71

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alviggi L., Johnston C., Hoskins P. J., Tee D. E., Pyke D. A., Leslie R. D., Vergani D. Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet. 1984 Jul 7;2(8393):4–6. doi: 10.1016/s0140-6736(84)91994-9. [DOI] [PubMed] [Google Scholar]
  2. Bottazzo G. F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974 Nov 30;2(7892):1279–1283. doi: 10.1016/s0140-6736(74)90140-8. [DOI] [PubMed] [Google Scholar]
  3. Buschard K., Röpke C., Madsbad S., Mehlsen J., Rygaard J. T lymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study. Diabetologia. 1983 Sep;25(3):247–251. doi: 10.1007/BF00279938. [DOI] [PubMed] [Google Scholar]
  4. Cahill G. F., Jr, McDevitt H. O. Insulin-dependent diabetes mellitus: the initial lesion. N Engl J Med. 1981 Jun 11;304(24):1454–1465. doi: 10.1056/NEJM198106113042403. [DOI] [PubMed] [Google Scholar]
  5. Clement L. T., Grossi C. E., Gartland G. L. Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. J Immunol. 1984 Nov;133(5):2461–2468. [PubMed] [Google Scholar]
  6. Dobersen M. J., Scharff J. E., Ginsberg-Fellner F., Notkins A. L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med. 1980 Dec 25;303(26):1493–1498. doi: 10.1056/NEJM198012253032601. [DOI] [PubMed] [Google Scholar]
  7. Galluzzo A., Giordano C., Rubino G., Bompiani G. D. Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984 Jun;26(6):426–430. doi: 10.1007/BF00262214. [DOI] [PubMed] [Google Scholar]
  8. Gepts W., Lecompte P. M. The pancreatic islets in diabetes. Am J Med. 1981 Jan;70(1):105–115. doi: 10.1016/0002-9343(81)90417-4. [DOI] [PubMed] [Google Scholar]
  9. Guttmann R. D., Colle E., Michel F., Seemayer T. Spontaneous diabetes mellitus syndrome in the rat. II. T lymphopenia and its association with clinical disease and pancreatic lymphocytic infiltration. J Immunol. 1983 Apr;130(4):1732–1735. [PubMed] [Google Scholar]
  10. Herold K. C., Huen A., Gould L., Traisman H., Rubenstein A. H. Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia. 1984 Jul;27 (Suppl):102–105. doi: 10.1007/BF00275660. [DOI] [PubMed] [Google Scholar]
  11. Horita M., Suzuki H., Onodera T., Ginsberg-Fellner F., Fauci A. S., Notkins A. L. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. J Immunol. 1982 Oct;129(4):1426–1429. [PubMed] [Google Scholar]
  12. Ilonen J., Surcel H. M., Mustonen A., Kär M. L., Akerblom H. K. Lymphocyte subpopulations at the onset of type 1 (insulin-dependent) diabetes. Diabetologia. 1984 Jul;27 (Suppl):106–108. doi: 10.1007/BF00275661. [DOI] [PubMed] [Google Scholar]
  13. Jackson R. A., Morris M. A., Haynes B. F., Eisenbarth G. S. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med. 1982 Apr 1;306(13):785–788. doi: 10.1056/NEJM198204013061305. [DOI] [PubMed] [Google Scholar]
  14. Kataoka S., Satoh J., Fujiya H., Toyota T., Suzuki R., Itoh K., Kumagai K. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes. 1983 Mar;32(3):247–253. doi: 10.2337/diab.32.3.247. [DOI] [PubMed] [Google Scholar]
  15. Lanier L. L., Warner N. L. Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis. J Immunol Methods. 1981;47(1):25–30. doi: 10.1016/0022-1759(81)90253-2. [DOI] [PubMed] [Google Scholar]
  16. Mascart-Lemone F., Delespesse G., Dorchy H., Lemiere B., Servais G. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies. Clin Exp Immunol. 1982 Feb;47(2):296–300. [PMC free article] [PubMed] [Google Scholar]
  17. Pozzilli P., Sensi M., Al-Sakkaf L., Tarn A., Zuccarini O., Bottazzo G. F. Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetes. Diabetologia. 1984 Jul;27 (Suppl):132–135. doi: 10.1007/BF00275670. [DOI] [PubMed] [Google Scholar]
  18. Pozzilli P., Zuccarini O., Iavicoli M., Andreani D., Sensi M., Spencer K. M., Bottazzo G. F., Beverley P. C., Kyner J. L., Cudworth A. G. Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes. Diabetes. 1983 Jan;32(1):91–94. doi: 10.2337/diab.32.1.91. [DOI] [PubMed] [Google Scholar]
  19. Selam J. L., Clot J., Andary M., Mirouze J. Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes. Correction of abnormalities by adequate blood glucose control. Diabetologia. 1979 Jan;16(1):35–40. doi: 10.1007/BF00423148. [DOI] [PubMed] [Google Scholar]
  20. Svejgaard A., Platz P., Ryder L. P. HLA and disease 1982--a survey. Immunol Rev. 1983;70:193–218. doi: 10.1111/j.1600-065x.1983.tb00715.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES